Events and Networking

Expand Your Network at One of Biocom’s 150+ Annual Events

Biocom CFO Series: Secrets of Alternative Funding

When

Wed Jun 28 14:00:00 GMT 2017 - Wed Jun 28 16:00:00 GMT 2017

Where

10996 Torreyana Road
San Diego, CA 92121

Register

Secrets of Alternative Funding: 
More Options and More Money for Life Sciences Than You Knew

Success in Life Science startups is a function of breakthrough research and creative funding.  While most Life Science startups flock to Venture Capitalists, only 1/100 typically get funded.  So what are the alternative funding mechanisms out there?  We invite you to join the Biocom CFO Breakfast Series on Wednesday, June 28th to learn from your other business colleagues about how they got their businesses off the ground with almost no funding from Venture Capitalists or traditional investment partners.

Leslie Schulze, CFO of Origami Therapeutics will share how she has played a significant role in helping companies obtain equity and non-dilutive funding, including government grants and contracts (with one award up to $90M from BARDA).  Additionally, Craig Misrach Founder and 8+ year CEO of Freedom Meditech, will share how he helped lead the company in receiving over 17MM in funding since inception, with a significant portion coming from Super Angel Investors (not Angel organizations) both domestically and abroad.​ Sabrina Martucci Johnson, Founder and CEO of Daré Bioscience, will share how Daré entered a stock purchase agreement as a transaction to create a NASDAQ-listed company and access capital.

Kicking off the panel discussion will be a State of the Industry Update led by Ernst & Young. 


Moderator:
Albert Oaten, Vice President of Market Development and Co-Founder, SecureDocs

Panelists: 
Sabrina Johnson, Founder & CEO, Dare Bioscience

Leslie Schulze, CFO, Origami Therapeutics

Craig Misrach, Investment Advisor, Founding CEO, Board Member


Agenda: 
7:00 am: Networking
7:45 am: State of the Industry Update led by Ernst & Young
8:00 am: Event Panel & Breakfast
9:00 am: Event Concludes

Learn more about the Biocom CFO Series here

*Please note: This event is intended for CFOs and/or Senior Executives of Finance only. In addition, this event is only open to C-level industry companies and closed to all service providers of Biocom, with the exception of our Premium Members. Only one person from our Premium Provider companies is able to attend and they must be a C-Level Executive. A service provider is a company that does not directly work with a substance that needs approval by the FDA and/or does business-to-business sales. They provide a service to the biotechnology and pharmaceutical industry and includes, but is not limited to, law firms, banks, laboratory equipment suppliers, consulting firms, or IT services.

Price of Admission

Biocom Member

Today's Price: 20.0

Important Dates

Amount

Registration Before

Registration Before

Registration Before

Refund after Tue Mar 28 00:00:00 GMT 2017

0.0

Refund after

Refund after

Non-Member (Industry Company Only)

Today's Price: 40.0

Important Dates

Amount

Registration Before

Registration Before

Registration Before

Refund after Tue Mar 28 00:00:00 GMT 2017

0.0

Refund after

Refund after

  • Biocom CFO Series

    About Biocom CFO Series

    The Biocom CFO Series is a series of events intended for CFOs and/or Senior Finance Executives, within the Life Sciences industry. The series will consist of three educational breakfast discussions each year, falling on the last Wednesday of each quarter, along with an end of the year CFO reception. This forum is designed to focus on issues pertinent to Chief Financial Officers of the life sciences industry and allow fellow CFOs to network with one another in an intimate setting. Attending these quarterly events is an ideal way to showcase your company in front of the community's financial leadership.


    2017 CFO Series Event Dates
    Wednesday, March 29th | 7-9am
    Wednesday, June 28th | 7-9am
    Wednesday, September 27th | 7-9am
    Wednesday, December 13th | 4:30-6:30pm (Holiday Reception)

    *Please note: This event is intended for CFOs and/or Senior Executives of Finance only. In addition, this event is only open to C-level industry companies and closed to all service providers of Biocom, with the exception of our Premium Members. Only one person from our Premium Provider companies is able to attend and they must be a C-Level Executive. A service provider is a company that does not directly work with a substance that needs approval by the FDA and/or does business-to-business sales. They provide a service to the biotechnology and pharmaceutical industry and includes, but is not limited to, law firms, banks, laboratory equipment suppliers, consulting firms, or IT services.

    a0d2A00000ByJDcQAN

    Go
  • Speaker Bios

    Sabrina Martucci Johnson, Founder and CEO, Dare Bioscience

    Sabrina is the Founder and CEO of DARÉ Bioscience, a healthcare company committed to the development and commercialization of innovative products in women’s reproductive health.  Prior to founding DARÉ, Sabrina was President of WomanCare Global Trading, a global provider of women’s health products.  She served as COO and CFO of Cypress Bioscience, Inc. (NASDAQ:CYPB) until its sale in 2010 and also held commercial operations positions with Advanced Tissue Sciences and Clonetics Corporation.  She began her career in the biotechnology industry as a research scientist with Baxter Healthcare.  In the community Sabrina serves on the board of organizations that advance the economic well-being of women and girls and promote education.  Sabrina has a Master of International Management with honors from the American Graduate School of International Management (Thunderbird); a MSc. in Biochemical Engineering from the University of London, University College London; and a BSc. in Biomedical Engineering from Tulane University, magna cum laude. 

    Craig Misrach, Investment Advisor, Founding CEO, Board Member, Freedom Meditech

    Craig Misrach, Founder and 8+ year CEO of Freedom Meditech, will share how he helped lead the company in receiving over 17MM in funding since inception, with a significant portion coming from Super Angel Investors (not Angel organizations) both domestically and abroad.​

    Leslie J. Schulze, CPA, CGMA, Co-Founder and Chief Financial Officer, Origami Therapeutics, Inc.

    Leslie J. Schulze has over 15 years of accounting and finance experience, primarily as a senior biotech executive in the start-up pharmaceutical industry.  Ms. Schulze formed her own consulting company 3 years ago to provide contract CFO services to small, start-up biotechs.  Notable clients include (1) Origami Therapeutics, Inc., as Co-Founder and Chief Financial Officer, a discovery stage start-up biotech currently raising seed funding and (2) Tripex Pharmaceuticals, LLC as the CFO working with the CEO to re-acquire a drug that was sold by a prior company 5 years earlier into a newly formed entity and sold the drug to a different pharmaceutical company within the same year.  Ms. Schulze was Co-Founder and Vice President, Finance and Administration of Rempex Pharmaceuticals, Inc., which was acquired by The Medicines Company in 2014.  Prior to helping found Rempex in 2011, Ms. Schulze served as Controller and Director of Finance at Mpex Pharmaceuticals, Inc., which was acquired by Axcan Holdings, Inc. in 2011.  Ms. Schulze has played a key role in venture capital (VC) financings, non-dilutive funding (including government contracts and grants), corporation collaborations, mergers and acquisitions, asset acquisitions/sales and the development of corporate infrastructure.  

    a0d2A00000BfijeQAB
    Go
  • Biocom CFO Series

    About Biocom CFO Series

    The Biocom CFO Series is a series of events intended for CFOs and/or Senior Finance Executives, within the Life Sciences industry. The series will consist of three educational breakfast discussions each year, falling on the last Wednesday of each quarter, along with an end of the year CFO reception. This forum is designed to focus on issues pertinent to Chief Financial Officers of the life sciences industry and allow fellow CFOs to network with one another in an intimate setting. Attending these quarterly events is an ideal way to showcase your company in front of the community's financial leadership.


    2017 CFO Series Event Dates
    Wednesday, March 29th | 7-9am
    Wednesday, June 28th | 7-9am
    Wednesday, September 27th | 7-9am
    Wednesday, December 13th | 4:30-6:30pm (Holiday Reception)

    *Please note: This event is intended for CFOs and/or Senior Executives of Finance only. In addition, this event is only open to C-level industry companies and closed to all service providers of Biocom, with the exception of our Premium Members. Only one person from our Premium Provider companies is able to attend and they must be a C-Level Executive. A service provider is a company that does not directly work with a substance that needs approval by the FDA and/or does business-to-business sales. They provide a service to the biotechnology and pharmaceutical industry and includes, but is not limited to, law firms, banks, laboratory equipment suppliers, consulting firms, or IT services.

    a0d2A00000ByJDcQAN

    Go
  • Biocom CFO Series

    About Biocom CFO Series

    The Biocom CFO Series is a series of events intended for CFOs and/or Senior Finance Executives, within the Life Sciences industry. The series will consist of three educational breakfast discussions each year, falling on the last Wednesday of each quarter, along with an end of the year CFO reception. This forum is designed to focus on issues pertinent to Chief Financial Officers of the life sciences industry and allow fellow CFOs to network with one another in an intimate setting. Attending these quarterly events is an ideal way to showcase your company in front of the community's financial leadership.


    2017 CFO Series Event Dates
    Wednesday, March 29th | 7-9am
    Wednesday, June 28th | 7-9am
    Wednesday, September 27th | 7-9am
    Wednesday, December 13th | 4:30-6:30pm (Holiday Reception)

    *Please note: This event is intended for CFOs and/or Senior Executives of Finance only. In addition, this event is only open to C-level industry companies and closed to all service providers of Biocom, with the exception of our Premium Members. Only one person from our Premium Provider companies is able to attend and they must be a C-Level Executive. A service provider is a company that does not directly work with a substance that needs approval by the FDA and/or does business-to-business sales. They provide a service to the biotechnology and pharmaceutical industry and includes, but is not limited to, law firms, banks, laboratory equipment suppliers, consulting firms, or IT services.

    a0d2A00000ByJDcQAN
    Go

Register